Outsourced Pharma

Outsourced Pharma
Share

Outsourced Pharma

 •  April 18

Sale of Oncology business unlocks embedded value within Shire’s portfolio and sharpens focus on core areas reinforcing our leadership in rare diseases Oncology business provides Servier with an immediate presence in the U.S., enhancing its commitment to addressing unmet patient needs in oncology Shire plc the leading global biotechnology company...

Outsourced Pharma

 •  April 17

East Rutherford, NJ (GLOBE NEWSWIRE) - Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has completed the installation of multiple continuous flow reactor platforms at its High Point, NC facility. The investment underpins Cambrex’s...

Outsourced Pharma

 •  April 12

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced it has completed a $5.5M expansion program at its 200,000+ square foot Philadelphia, Pennsylvania, site to provide additional clinical packaging and storage...

Outsourced Pharma

 •  April 4

Collaboration will provide clients competitive advantages, improve speed to market KBI makes equity investment in ReForm Biologics along with existing investors ReForm Biologics and KBI Biopharma, Inc., (KBI) recently announced a strategic partnership to make improved biopharmaceutical formulations. Through this collaboration, KBI and ReForm will...

Outsourced Pharma

 •  April 3

Sumitomo Dainippon Pharma Co. Ltd. has installed the GigaSort Platform in their newly opened Manufacturing Plant for Regenerative Medicine & Cell Therapy in Osaka, Japan. The center is the world’s first commercial iPSC plant. The GigaSort platform is a microfluidic-based cell sorting technology that allows the selection of highly specific and pure...

Outsourced Pharma

 •  March 28

IDIFARMA has announced new GMP spray drying capabilities which will make it one of the very few contract development and manufacturing organisations (CDMO) to offer spray drying technology for highly potent drugs up to Category 4 OEL/OEB. The Spanish CDMO, which specialises in niche and highly potent products, will be one of only three companies in...

Outsourced Pharma

 •  March 28

The Falsified Medicines Directive (FMD) imposes strict serialisation requirements on pharmaceutical manufacturers, distributors and dispensers. Mark Davison, Head of Operations in the EU for rfxcel, outlines everything you need to know and what you need to do for a seamless serialisation process – before regulators remove your right to...

Outsourced Pharma

 •  March 20

GRAND RAPIDS, MICH.--(BUSINESS WIRE)-- Grand River Aseptic Manufacturing, Inc. (GRAM), a leading parenteral contract manufacturing organization, has signed purchase agreements to acquire land in Grand Rapids, Michigan, to add to its growing presence in life sciences, expand its manufacturing capacity and serve its growing customer base. The...

Outsourced Pharma

 •  March 16

Recipharm, the contract development and manufacturing organization (CDMO), has announced an €18 million investment to expand its blow fill seal (BFS) capacity at its site in Kaysersberg, France The investment will see the introduction of a new blow fill seal high speed filling and packaging line, bringing the total number of lines from seven to...

Outsourced Pharma

 •  March 14

Recipharm, the contract development and manufacturing organisation (CDMO), announces its new blow-fill-seal machinery is now operational following a substantial investment last year at its facility in Kaysersberg, France. The EUR 18 million investment adds a new blow-fill-seal high-speed filling and packaging line to the site, taking the total...